September 19, 2011
September 19, 2011 —
Five bioengineering Ph.D. students from the University of California, San Diego whose research is aimed at improving human health are among the 2012 recipients of the annual Siebel Scholars awards.
October 3, 2022
October 3, 2022 —
UC San Diego study finds enhanced PKCγ activity drives spinocerebellar ataxia type 14; suggests inhibiting the enzyme may have therapeutic potential
June 2, 2022
June 2, 2022 —
UC San Diego researchers report significant progress in understanding how the combined effects of rare mutations and common genetic variation in determining whether a child will develop ASD and its consequential effects.
March 27, 2013
March 27, 2013 —
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, says a key protein in Schwann cells performs a critical, perhaps overarching, role in regulating the recovery of peripheral nerves after injury. The discovery has implications for improving the treatment of neuropathic…
February 4, 2019
February 4, 2019 —
Researchers at UC San Diego and Arizona State University have received $1.7 million in funding from The Michael J. Fox Foundation for Parkinson’s Research to launch a multi-year effort to identify blood-based biomarkers of Parkinson’s disease, which could improve care and accelerate new treatments.
May 11, 2017
May 11, 2017 —
By applying a novel computer algorithm to mimic how the brain learns, a team of researchers – with the aid of the Comet supercomputer based at the San Diego Supercomputer Center (SDSC) at UC San Diego – has identified and replicated neural circuitry that resembles the way an unimpaired brain…
August 11, 2014
August 11, 2014 —
Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study.
June 1, 2018
June 1, 2018 —
Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.
December 7, 2015
December 7, 2015 —
Currently, there is no treatment to halt the progression of Huntington’s disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope…
October 6, 2021
October 6, 2021 —
In a special issue of Nature, UC San Diego researchers further refine the organization of cells within key regions of the mouse brain and the organization of transcriptomic, epigenomic and regulatory factors that provide these brain cells with function and purpose.